nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—HTR1A—stomach cancer	0.468	1	CbGaD
Ropinirole—HTR2A—myenteric nerve plexus—stomach cancer	0.0051	0.139	CbGeAlD
Ropinirole—HTR2A—vagus nerve—stomach cancer	0.0034	0.0929	CbGeAlD
Ropinirole—HTR2A—vein—stomach cancer	0.00329	0.0897	CbGeAlD
Ropinirole—HTR1B—blood vessel—stomach cancer	0.00217	0.0592	CbGeAlD
Ropinirole—HTR1D—blood vessel—stomach cancer	0.0021	0.0573	CbGeAlD
Ropinirole—DRD5—hematopoietic system—stomach cancer	0.00187	0.0509	CbGeAlD
Ropinirole—DRD5—lymphoid tissue—stomach cancer	0.00131	0.0358	CbGeAlD
Ropinirole—DRD5—endocrine gland—stomach cancer	0.00107	0.0293	CbGeAlD
Ropinirole—HTR2A—blood vessel—stomach cancer	0.00104	0.0285	CbGeAlD
Ropinirole—HTR1A—hematopoietic system—stomach cancer	0.000932	0.0254	CbGeAlD
Ropinirole—HTR2B—smooth muscle tissue—stomach cancer	0.000916	0.025	CbGeAlD
Ropinirole—HTR2B—digestive system—stomach cancer	0.000724	0.0197	CbGeAlD
Ropinirole—CYP1A2—hematopoietic system—stomach cancer	0.000711	0.0194	CbGeAlD
Ropinirole—ADRA2C—pancreas—stomach cancer	0.000667	0.0182	CbGeAlD
Ropinirole—HTR1B—endocrine gland—stomach cancer	0.000664	0.0181	CbGeAlD
Ropinirole—ADRA2A—hematopoietic system—stomach cancer	0.000653	0.0178	CbGeAlD
Ropinirole—HTR2A—hematopoietic system—stomach cancer	0.000556	0.0152	CbGeAlD
Ropinirole—HTR1A—endocrine gland—stomach cancer	0.000536	0.0146	CbGeAlD
Ropinirole—ADRA2A—pancreas—stomach cancer	0.000532	0.0145	CbGeAlD
Ropinirole—CYP3A4—hematopoietic system—stomach cancer	0.000514	0.014	CbGeAlD
Ropinirole—HTR2A—epithelium—stomach cancer	0.000508	0.0139	CbGeAlD
Ropinirole—CYP2D6—hematopoietic system—stomach cancer	0.000506	0.0138	CbGeAlD
Ropinirole—CYP1A2—digestive system—stomach cancer	0.000494	0.0135	CbGeAlD
Ropinirole—HTR2A—smooth muscle tissue—stomach cancer	0.000489	0.0134	CbGeAlD
Ropinirole—DRD2—endocrine gland—stomach cancer	0.000484	0.0132	CbGeAlD
Ropinirole—ADRA2C—liver—stomach cancer	0.000424	0.0116	CbGeAlD
Ropinirole—HTR2B—lymph node—stomach cancer	0.000413	0.0113	CbGeAlD
Ropinirole—CYP1A2—endocrine gland—stomach cancer	0.000408	0.0111	CbGeAlD
Ropinirole—HTR2A—digestive system—stomach cancer	0.000386	0.0105	CbGeAlD
Ropinirole—ADRA2A—endocrine gland—stomach cancer	0.000376	0.0102	CbGeAlD
Ropinirole—CYP1A2—liver—stomach cancer	0.000368	0.01	CbGeAlD
Ropinirole—CYP3A4—digestive system—stomach cancer	0.000358	0.00976	CbGeAlD
Ropinirole—CYP2D6—digestive system—stomach cancer	0.000352	0.00961	CbGeAlD
Ropinirole—ADRA2C—lymph node—stomach cancer	0.000325	0.00888	CbGeAlD
Ropinirole—HTR2A—endocrine gland—stomach cancer	0.000319	0.00871	CbGeAlD
Ropinirole—CYP3A4—endocrine gland—stomach cancer	0.000296	0.00807	CbGeAlD
Ropinirole—CYP2D6—endocrine gland—stomach cancer	0.000291	0.00794	CbGeAlD
Ropinirole—HTR2A—liver—stomach cancer	0.000288	0.00786	CbGeAlD
Ropinirole—CYP3A4—liver—stomach cancer	0.000267	0.00727	CbGeAlD
Ropinirole—CYP2D6—liver—stomach cancer	0.000262	0.00716	CbGeAlD
Ropinirole—ADRA2A—lymph node—stomach cancer	0.00026	0.00708	CbGeAlD
Ropinirole—Haemorrhage—Doxorubicin—stomach cancer	8.12e-05	0.000238	CcSEcCtD
Ropinirole—Insomnia—Capecitabine—stomach cancer	8.1e-05	0.000237	CcSEcCtD
Ropinirole—Hypoaesthesia—Doxorubicin—stomach cancer	8.08e-05	0.000236	CcSEcCtD
Ropinirole—Rash—Fluorouracil—stomach cancer	8.08e-05	0.000236	CcSEcCtD
Ropinirole—Dermatitis—Fluorouracil—stomach cancer	8.07e-05	0.000236	CcSEcCtD
Ropinirole—Pharyngitis—Doxorubicin—stomach cancer	8.06e-05	0.000236	CcSEcCtD
Ropinirole—Paraesthesia—Capecitabine—stomach cancer	8.04e-05	0.000235	CcSEcCtD
Ropinirole—Decreased appetite—Docetaxel—stomach cancer	8.04e-05	0.000235	CcSEcCtD
Ropinirole—Headache—Fluorouracil—stomach cancer	8.02e-05	0.000235	CcSEcCtD
Ropinirole—Urinary tract disorder—Doxorubicin—stomach cancer	8.02e-05	0.000235	CcSEcCtD
Ropinirole—Oedema peripheral—Doxorubicin—stomach cancer	8e-05	0.000234	CcSEcCtD
Ropinirole—Dysgeusia—Methotrexate—stomach cancer	7.99e-05	0.000234	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Docetaxel—stomach cancer	7.98e-05	0.000234	CcSEcCtD
Ropinirole—Connective tissue disorder—Doxorubicin—stomach cancer	7.98e-05	0.000234	CcSEcCtD
Ropinirole—Dyspnoea—Capecitabine—stomach cancer	7.98e-05	0.000233	CcSEcCtD
Ropinirole—Fatigue—Docetaxel—stomach cancer	7.97e-05	0.000233	CcSEcCtD
Ropinirole—Angiopathy—Epirubicin—stomach cancer	7.96e-05	0.000233	CcSEcCtD
Ropinirole—Urethral disorder—Doxorubicin—stomach cancer	7.96e-05	0.000233	CcSEcCtD
Ropinirole—Nausea—Irinotecan—stomach cancer	7.94e-05	0.000232	CcSEcCtD
Ropinirole—Immune system disorder—Epirubicin—stomach cancer	7.93e-05	0.000232	CcSEcCtD
Ropinirole—Mediastinal disorder—Epirubicin—stomach cancer	7.91e-05	0.000231	CcSEcCtD
Ropinirole—Constipation—Docetaxel—stomach cancer	7.91e-05	0.000231	CcSEcCtD
Ropinirole—Pain—Docetaxel—stomach cancer	7.91e-05	0.000231	CcSEcCtD
Ropinirole—Back pain—Methotrexate—stomach cancer	7.9e-05	0.000231	CcSEcCtD
Ropinirole—Dyspepsia—Capecitabine—stomach cancer	7.88e-05	0.000231	CcSEcCtD
Ropinirole—Chills—Epirubicin—stomach cancer	7.88e-05	0.00023	CcSEcCtD
Ropinirole—Arrhythmia—Epirubicin—stomach cancer	7.84e-05	0.000229	CcSEcCtD
Ropinirole—Visual impairment—Doxorubicin—stomach cancer	7.83e-05	0.000229	CcSEcCtD
Ropinirole—Decreased appetite—Capecitabine—stomach cancer	7.78e-05	0.000228	CcSEcCtD
Ropinirole—Alopecia—Epirubicin—stomach cancer	7.76e-05	0.000227	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Capecitabine—stomach cancer	7.73e-05	0.000226	CcSEcCtD
Ropinirole—Fatigue—Capecitabine—stomach cancer	7.72e-05	0.000226	CcSEcCtD
Ropinirole—Vision blurred—Methotrexate—stomach cancer	7.69e-05	0.000225	CcSEcCtD
Ropinirole—Mental disorder—Epirubicin—stomach cancer	7.69e-05	0.000225	CcSEcCtD
Ropinirole—Pain—Capecitabine—stomach cancer	7.65e-05	0.000224	CcSEcCtD
Ropinirole—Constipation—Capecitabine—stomach cancer	7.65e-05	0.000224	CcSEcCtD
Ropinirole—Malnutrition—Epirubicin—stomach cancer	7.64e-05	0.000224	CcSEcCtD
Ropinirole—Feeling abnormal—Docetaxel—stomach cancer	7.62e-05	0.000223	CcSEcCtD
Ropinirole—Nausea—Fluorouracil—stomach cancer	7.61e-05	0.000223	CcSEcCtD
Ropinirole—Eye disorder—Doxorubicin—stomach cancer	7.59e-05	0.000222	CcSEcCtD
Ropinirole—Ill-defined disorder—Methotrexate—stomach cancer	7.57e-05	0.000222	CcSEcCtD
Ropinirole—Tinnitus—Doxorubicin—stomach cancer	7.57e-05	0.000222	CcSEcCtD
Ropinirole—Gastrointestinal pain—Docetaxel—stomach cancer	7.56e-05	0.000221	CcSEcCtD
Ropinirole—Anaemia—Methotrexate—stomach cancer	7.55e-05	0.000221	CcSEcCtD
Ropinirole—Flushing—Doxorubicin—stomach cancer	7.54e-05	0.000221	CcSEcCtD
Ropinirole—Cardiac disorder—Doxorubicin—stomach cancer	7.54e-05	0.000221	CcSEcCtD
Ropinirole—Flatulence—Epirubicin—stomach cancer	7.53e-05	0.00022	CcSEcCtD
Ropinirole—Tension—Epirubicin—stomach cancer	7.5e-05	0.000219	CcSEcCtD
Ropinirole—Dysgeusia—Epirubicin—stomach cancer	7.48e-05	0.000219	CcSEcCtD
Ropinirole—Nervousness—Epirubicin—stomach cancer	7.42e-05	0.000217	CcSEcCtD
Ropinirole—Back pain—Epirubicin—stomach cancer	7.39e-05	0.000216	CcSEcCtD
Ropinirole—Feeling abnormal—Capecitabine—stomach cancer	7.38e-05	0.000216	CcSEcCtD
Ropinirole—Angiopathy—Doxorubicin—stomach cancer	7.37e-05	0.000216	CcSEcCtD
Ropinirole—Malaise—Methotrexate—stomach cancer	7.36e-05	0.000215	CcSEcCtD
Ropinirole—Muscle spasms—Epirubicin—stomach cancer	7.35e-05	0.000215	CcSEcCtD
Ropinirole—Immune system disorder—Doxorubicin—stomach cancer	7.34e-05	0.000215	CcSEcCtD
Ropinirole—Vertigo—Methotrexate—stomach cancer	7.34e-05	0.000215	CcSEcCtD
Ropinirole—Gastrointestinal pain—Capecitabine—stomach cancer	7.32e-05	0.000214	CcSEcCtD
Ropinirole—Mediastinal disorder—Doxorubicin—stomach cancer	7.32e-05	0.000214	CcSEcCtD
Ropinirole—Abdominal pain—Docetaxel—stomach cancer	7.31e-05	0.000214	CcSEcCtD
Ropinirole—Body temperature increased—Docetaxel—stomach cancer	7.31e-05	0.000214	CcSEcCtD
Ropinirole—Leukopenia—Methotrexate—stomach cancer	7.31e-05	0.000214	CcSEcCtD
Ropinirole—Chills—Doxorubicin—stomach cancer	7.29e-05	0.000213	CcSEcCtD
Ropinirole—Arrhythmia—Doxorubicin—stomach cancer	7.25e-05	0.000212	CcSEcCtD
Ropinirole—Vision blurred—Epirubicin—stomach cancer	7.2e-05	0.000211	CcSEcCtD
Ropinirole—Alopecia—Doxorubicin—stomach cancer	7.18e-05	0.00021	CcSEcCtD
Ropinirole—Cough—Methotrexate—stomach cancer	7.12e-05	0.000208	CcSEcCtD
Ropinirole—Mental disorder—Doxorubicin—stomach cancer	7.11e-05	0.000208	CcSEcCtD
Ropinirole—Urticaria—Capecitabine—stomach cancer	7.11e-05	0.000208	CcSEcCtD
Ropinirole—Ill-defined disorder—Epirubicin—stomach cancer	7.09e-05	0.000207	CcSEcCtD
Ropinirole—Abdominal pain—Capecitabine—stomach cancer	7.08e-05	0.000207	CcSEcCtD
Ropinirole—Body temperature increased—Capecitabine—stomach cancer	7.08e-05	0.000207	CcSEcCtD
Ropinirole—Convulsion—Methotrexate—stomach cancer	7.07e-05	0.000207	CcSEcCtD
Ropinirole—Malnutrition—Doxorubicin—stomach cancer	7.07e-05	0.000207	CcSEcCtD
Ropinirole—Anaemia—Epirubicin—stomach cancer	7.06e-05	0.000207	CcSEcCtD
Ropinirole—Agitation—Epirubicin—stomach cancer	7.02e-05	0.000205	CcSEcCtD
Ropinirole—Flatulence—Doxorubicin—stomach cancer	6.97e-05	0.000204	CcSEcCtD
Ropinirole—Arthralgia—Methotrexate—stomach cancer	6.95e-05	0.000203	CcSEcCtD
Ropinirole—Myalgia—Methotrexate—stomach cancer	6.95e-05	0.000203	CcSEcCtD
Ropinirole—Chest pain—Methotrexate—stomach cancer	6.95e-05	0.000203	CcSEcCtD
Ropinirole—Tension—Doxorubicin—stomach cancer	6.94e-05	0.000203	CcSEcCtD
Ropinirole—Dysgeusia—Doxorubicin—stomach cancer	6.92e-05	0.000203	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	6.9e-05	0.000202	CcSEcCtD
Ropinirole—Malaise—Epirubicin—stomach cancer	6.89e-05	0.000202	CcSEcCtD
Ropinirole—Discomfort—Methotrexate—stomach cancer	6.87e-05	0.000201	CcSEcCtD
Ropinirole—Nervousness—Doxorubicin—stomach cancer	6.87e-05	0.000201	CcSEcCtD
Ropinirole—Vertigo—Epirubicin—stomach cancer	6.86e-05	0.000201	CcSEcCtD
Ropinirole—Syncope—Epirubicin—stomach cancer	6.85e-05	0.0002	CcSEcCtD
Ropinirole—Leukopenia—Epirubicin—stomach cancer	6.84e-05	0.0002	CcSEcCtD
Ropinirole—Back pain—Doxorubicin—stomach cancer	6.84e-05	0.0002	CcSEcCtD
Ropinirole—Hypersensitivity—Docetaxel—stomach cancer	6.81e-05	0.000199	CcSEcCtD
Ropinirole—Muscle spasms—Doxorubicin—stomach cancer	6.8e-05	0.000199	CcSEcCtD
Ropinirole—Palpitations—Epirubicin—stomach cancer	6.75e-05	0.000198	CcSEcCtD
Ropinirole—Confusional state—Methotrexate—stomach cancer	6.72e-05	0.000197	CcSEcCtD
Ropinirole—Loss of consciousness—Epirubicin—stomach cancer	6.72e-05	0.000196	CcSEcCtD
Ropinirole—Cough—Epirubicin—stomach cancer	6.67e-05	0.000195	CcSEcCtD
Ropinirole—Vision blurred—Doxorubicin—stomach cancer	6.66e-05	0.000195	CcSEcCtD
Ropinirole—Asthenia—Docetaxel—stomach cancer	6.63e-05	0.000194	CcSEcCtD
Ropinirole—Convulsion—Epirubicin—stomach cancer	6.62e-05	0.000194	CcSEcCtD
Ropinirole—Infection—Methotrexate—stomach cancer	6.62e-05	0.000194	CcSEcCtD
Ropinirole—Hypertension—Epirubicin—stomach cancer	6.6e-05	0.000193	CcSEcCtD
Ropinirole—Hypersensitivity—Capecitabine—stomach cancer	6.59e-05	0.000193	CcSEcCtD
Ropinirole—Ill-defined disorder—Doxorubicin—stomach cancer	6.56e-05	0.000192	CcSEcCtD
Ropinirole—Pruritus—Docetaxel—stomach cancer	6.54e-05	0.000191	CcSEcCtD
Ropinirole—Nervous system disorder—Methotrexate—stomach cancer	6.53e-05	0.000191	CcSEcCtD
Ropinirole—Anaemia—Doxorubicin—stomach cancer	6.53e-05	0.000191	CcSEcCtD
Ropinirole—Thrombocytopenia—Methotrexate—stomach cancer	6.52e-05	0.000191	CcSEcCtD
Ropinirole—Myalgia—Epirubicin—stomach cancer	6.5e-05	0.00019	CcSEcCtD
Ropinirole—Arthralgia—Epirubicin—stomach cancer	6.5e-05	0.00019	CcSEcCtD
Ropinirole—Chest pain—Epirubicin—stomach cancer	6.5e-05	0.00019	CcSEcCtD
Ropinirole—Agitation—Doxorubicin—stomach cancer	6.5e-05	0.00019	CcSEcCtD
Ropinirole—Anxiety—Epirubicin—stomach cancer	6.48e-05	0.00019	CcSEcCtD
Ropinirole—Skin disorder—Methotrexate—stomach cancer	6.47e-05	0.000189	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	6.46e-05	0.000189	CcSEcCtD
Ropinirole—Hyperhidrosis—Methotrexate—stomach cancer	6.44e-05	0.000188	CcSEcCtD
Ropinirole—Discomfort—Epirubicin—stomach cancer	6.43e-05	0.000188	CcSEcCtD
Ropinirole—Asthenia—Capecitabine—stomach cancer	6.42e-05	0.000188	CcSEcCtD
Ropinirole—Malaise—Doxorubicin—stomach cancer	6.38e-05	0.000187	CcSEcCtD
Ropinirole—Dry mouth—Epirubicin—stomach cancer	6.36e-05	0.000186	CcSEcCtD
Ropinirole—Vertigo—Doxorubicin—stomach cancer	6.35e-05	0.000186	CcSEcCtD
Ropinirole—Anorexia—Methotrexate—stomach cancer	6.35e-05	0.000186	CcSEcCtD
Ropinirole—Syncope—Doxorubicin—stomach cancer	6.34e-05	0.000186	CcSEcCtD
Ropinirole—Pruritus—Capecitabine—stomach cancer	6.33e-05	0.000185	CcSEcCtD
Ropinirole—Leukopenia—Doxorubicin—stomach cancer	6.33e-05	0.000185	CcSEcCtD
Ropinirole—Diarrhoea—Docetaxel—stomach cancer	6.33e-05	0.000185	CcSEcCtD
Ropinirole—Confusional state—Epirubicin—stomach cancer	6.29e-05	0.000184	CcSEcCtD
Ropinirole—Palpitations—Doxorubicin—stomach cancer	6.25e-05	0.000183	CcSEcCtD
Ropinirole—Oedema—Epirubicin—stomach cancer	6.24e-05	0.000182	CcSEcCtD
Ropinirole—Hypotension—Methotrexate—stomach cancer	6.23e-05	0.000182	CcSEcCtD
Ropinirole—Loss of consciousness—Doxorubicin—stomach cancer	6.21e-05	0.000182	CcSEcCtD
Ropinirole—Infection—Epirubicin—stomach cancer	6.19e-05	0.000181	CcSEcCtD
Ropinirole—Cough—Doxorubicin—stomach cancer	6.17e-05	0.000181	CcSEcCtD
Ropinirole—Shock—Epirubicin—stomach cancer	6.13e-05	0.00018	CcSEcCtD
Ropinirole—Convulsion—Doxorubicin—stomach cancer	6.13e-05	0.000179	CcSEcCtD
Ropinirole—Diarrhoea—Capecitabine—stomach cancer	6.12e-05	0.000179	CcSEcCtD
Ropinirole—Nervous system disorder—Epirubicin—stomach cancer	6.12e-05	0.000179	CcSEcCtD
Ropinirole—Dizziness—Docetaxel—stomach cancer	6.11e-05	0.000179	CcSEcCtD
Ropinirole—Thrombocytopenia—Epirubicin—stomach cancer	6.11e-05	0.000179	CcSEcCtD
Ropinirole—Hypertension—Doxorubicin—stomach cancer	6.1e-05	0.000179	CcSEcCtD
Ropinirole—Tachycardia—Epirubicin—stomach cancer	6.09e-05	0.000178	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Methotrexate—stomach cancer	6.07e-05	0.000178	CcSEcCtD
Ropinirole—Skin disorder—Epirubicin—stomach cancer	6.06e-05	0.000177	CcSEcCtD
Ropinirole—Hyperhidrosis—Epirubicin—stomach cancer	6.03e-05	0.000176	CcSEcCtD
Ropinirole—Insomnia—Methotrexate—stomach cancer	6.03e-05	0.000176	CcSEcCtD
Ropinirole—Chest pain—Doxorubicin—stomach cancer	6.02e-05	0.000176	CcSEcCtD
Ropinirole—Myalgia—Doxorubicin—stomach cancer	6.02e-05	0.000176	CcSEcCtD
Ropinirole—Arthralgia—Doxorubicin—stomach cancer	6.02e-05	0.000176	CcSEcCtD
Ropinirole—Anxiety—Doxorubicin—stomach cancer	6e-05	0.000175	CcSEcCtD
Ropinirole—Paraesthesia—Methotrexate—stomach cancer	5.98e-05	0.000175	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	5.98e-05	0.000175	CcSEcCtD
Ropinirole—Discomfort—Doxorubicin—stomach cancer	5.95e-05	0.000174	CcSEcCtD
Ropinirole—Anorexia—Epirubicin—stomach cancer	5.94e-05	0.000174	CcSEcCtD
Ropinirole—Dyspnoea—Methotrexate—stomach cancer	5.94e-05	0.000174	CcSEcCtD
Ropinirole—Somnolence—Methotrexate—stomach cancer	5.92e-05	0.000173	CcSEcCtD
Ropinirole—Dizziness—Capecitabine—stomach cancer	5.92e-05	0.000173	CcSEcCtD
Ropinirole—Dry mouth—Doxorubicin—stomach cancer	5.89e-05	0.000172	CcSEcCtD
Ropinirole—Vomiting—Docetaxel—stomach cancer	5.88e-05	0.000172	CcSEcCtD
Ropinirole—Dyspepsia—Methotrexate—stomach cancer	5.87e-05	0.000172	CcSEcCtD
Ropinirole—Rash—Docetaxel—stomach cancer	5.83e-05	0.000171	CcSEcCtD
Ropinirole—Hypotension—Epirubicin—stomach cancer	5.83e-05	0.00017	CcSEcCtD
Ropinirole—Dermatitis—Docetaxel—stomach cancer	5.82e-05	0.00017	CcSEcCtD
Ropinirole—Confusional state—Doxorubicin—stomach cancer	5.82e-05	0.00017	CcSEcCtD
Ropinirole—Decreased appetite—Methotrexate—stomach cancer	5.79e-05	0.000169	CcSEcCtD
Ropinirole—Headache—Docetaxel—stomach cancer	5.79e-05	0.000169	CcSEcCtD
Ropinirole—Oedema—Doxorubicin—stomach cancer	5.77e-05	0.000169	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Methotrexate—stomach cancer	5.75e-05	0.000168	CcSEcCtD
Ropinirole—Fatigue—Methotrexate—stomach cancer	5.74e-05	0.000168	CcSEcCtD
Ropinirole—Infection—Doxorubicin—stomach cancer	5.73e-05	0.000168	CcSEcCtD
Ropinirole—Pain—Methotrexate—stomach cancer	5.7e-05	0.000167	CcSEcCtD
Ropinirole—Vomiting—Capecitabine—stomach cancer	5.69e-05	0.000167	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Epirubicin—stomach cancer	5.68e-05	0.000166	CcSEcCtD
Ropinirole—Shock—Doxorubicin—stomach cancer	5.68e-05	0.000166	CcSEcCtD
Ropinirole—Nervous system disorder—Doxorubicin—stomach cancer	5.66e-05	0.000166	CcSEcCtD
Ropinirole—Thrombocytopenia—Doxorubicin—stomach cancer	5.65e-05	0.000165	CcSEcCtD
Ropinirole—Rash—Capecitabine—stomach cancer	5.64e-05	0.000165	CcSEcCtD
Ropinirole—Insomnia—Epirubicin—stomach cancer	5.64e-05	0.000165	CcSEcCtD
Ropinirole—Dermatitis—Capecitabine—stomach cancer	5.64e-05	0.000165	CcSEcCtD
Ropinirole—Tachycardia—Doxorubicin—stomach cancer	5.63e-05	0.000165	CcSEcCtD
Ropinirole—Headache—Capecitabine—stomach cancer	5.61e-05	0.000164	CcSEcCtD
Ropinirole—Skin disorder—Doxorubicin—stomach cancer	5.6e-05	0.000164	CcSEcCtD
Ropinirole—Paraesthesia—Epirubicin—stomach cancer	5.6e-05	0.000164	CcSEcCtD
Ropinirole—Hyperhidrosis—Doxorubicin—stomach cancer	5.58e-05	0.000163	CcSEcCtD
Ropinirole—Dyspnoea—Epirubicin—stomach cancer	5.56e-05	0.000163	CcSEcCtD
Ropinirole—Somnolence—Epirubicin—stomach cancer	5.54e-05	0.000162	CcSEcCtD
Ropinirole—Anorexia—Doxorubicin—stomach cancer	5.5e-05	0.000161	CcSEcCtD
Ropinirole—Nausea—Docetaxel—stomach cancer	5.49e-05	0.000161	CcSEcCtD
Ropinirole—Feeling abnormal—Methotrexate—stomach cancer	5.49e-05	0.000161	CcSEcCtD
Ropinirole—Dyspepsia—Epirubicin—stomach cancer	5.49e-05	0.000161	CcSEcCtD
Ropinirole—Gastrointestinal pain—Methotrexate—stomach cancer	5.45e-05	0.000159	CcSEcCtD
Ropinirole—Decreased appetite—Epirubicin—stomach cancer	5.42e-05	0.000159	CcSEcCtD
Ropinirole—Hypotension—Doxorubicin—stomach cancer	5.39e-05	0.000158	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Epirubicin—stomach cancer	5.38e-05	0.000158	CcSEcCtD
Ropinirole—Fatigue—Epirubicin—stomach cancer	5.38e-05	0.000157	CcSEcCtD
Ropinirole—Pain—Epirubicin—stomach cancer	5.33e-05	0.000156	CcSEcCtD
Ropinirole—Constipation—Epirubicin—stomach cancer	5.33e-05	0.000156	CcSEcCtD
Ropinirole—Nausea—Capecitabine—stomach cancer	5.32e-05	0.000156	CcSEcCtD
Ropinirole—Urticaria—Methotrexate—stomach cancer	5.29e-05	0.000155	CcSEcCtD
Ropinirole—Abdominal pain—Methotrexate—stomach cancer	5.27e-05	0.000154	CcSEcCtD
Ropinirole—Body temperature increased—Methotrexate—stomach cancer	5.27e-05	0.000154	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Doxorubicin—stomach cancer	5.26e-05	0.000154	CcSEcCtD
Ropinirole—Insomnia—Doxorubicin—stomach cancer	5.22e-05	0.000153	CcSEcCtD
Ropinirole—Paraesthesia—Doxorubicin—stomach cancer	5.18e-05	0.000152	CcSEcCtD
Ropinirole—Dyspnoea—Doxorubicin—stomach cancer	5.14e-05	0.000151	CcSEcCtD
Ropinirole—Feeling abnormal—Epirubicin—stomach cancer	5.14e-05	0.00015	CcSEcCtD
Ropinirole—Somnolence—Doxorubicin—stomach cancer	5.13e-05	0.00015	CcSEcCtD
Ropinirole—Gastrointestinal pain—Epirubicin—stomach cancer	5.1e-05	0.000149	CcSEcCtD
Ropinirole—Dyspepsia—Doxorubicin—stomach cancer	5.08e-05	0.000149	CcSEcCtD
Ropinirole—Decreased appetite—Doxorubicin—stomach cancer	5.02e-05	0.000147	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Doxorubicin—stomach cancer	4.98e-05	0.000146	CcSEcCtD
Ropinirole—Fatigue—Doxorubicin—stomach cancer	4.97e-05	0.000146	CcSEcCtD
Ropinirole—Urticaria—Epirubicin—stomach cancer	4.95e-05	0.000145	CcSEcCtD
Ropinirole—Constipation—Doxorubicin—stomach cancer	4.93e-05	0.000144	CcSEcCtD
Ropinirole—Pain—Doxorubicin—stomach cancer	4.93e-05	0.000144	CcSEcCtD
Ropinirole—Abdominal pain—Epirubicin—stomach cancer	4.93e-05	0.000144	CcSEcCtD
Ropinirole—Body temperature increased—Epirubicin—stomach cancer	4.93e-05	0.000144	CcSEcCtD
Ropinirole—Hypersensitivity—Methotrexate—stomach cancer	4.91e-05	0.000144	CcSEcCtD
Ropinirole—Asthenia—Methotrexate—stomach cancer	4.78e-05	0.00014	CcSEcCtD
Ropinirole—Feeling abnormal—Doxorubicin—stomach cancer	4.75e-05	0.000139	CcSEcCtD
Ropinirole—Gastrointestinal pain—Doxorubicin—stomach cancer	4.72e-05	0.000138	CcSEcCtD
Ropinirole—Pruritus—Methotrexate—stomach cancer	4.71e-05	0.000138	CcSEcCtD
Ropinirole—Hypersensitivity—Epirubicin—stomach cancer	4.59e-05	0.000134	CcSEcCtD
Ropinirole—Urticaria—Doxorubicin—stomach cancer	4.58e-05	0.000134	CcSEcCtD
Ropinirole—Body temperature increased—Doxorubicin—stomach cancer	4.56e-05	0.000133	CcSEcCtD
Ropinirole—Abdominal pain—Doxorubicin—stomach cancer	4.56e-05	0.000133	CcSEcCtD
Ropinirole—Diarrhoea—Methotrexate—stomach cancer	4.56e-05	0.000133	CcSEcCtD
Ropinirole—Asthenia—Epirubicin—stomach cancer	4.47e-05	0.000131	CcSEcCtD
Ropinirole—Pruritus—Epirubicin—stomach cancer	4.41e-05	0.000129	CcSEcCtD
Ropinirole—Dizziness—Methotrexate—stomach cancer	4.41e-05	0.000129	CcSEcCtD
Ropinirole—Diarrhoea—Epirubicin—stomach cancer	4.27e-05	0.000125	CcSEcCtD
Ropinirole—Hypersensitivity—Doxorubicin—stomach cancer	4.25e-05	0.000124	CcSEcCtD
Ropinirole—Vomiting—Methotrexate—stomach cancer	4.24e-05	0.000124	CcSEcCtD
Ropinirole—Rash—Methotrexate—stomach cancer	4.2e-05	0.000123	CcSEcCtD
Ropinirole—Dermatitis—Methotrexate—stomach cancer	4.2e-05	0.000123	CcSEcCtD
Ropinirole—Headache—Methotrexate—stomach cancer	4.17e-05	0.000122	CcSEcCtD
Ropinirole—Asthenia—Doxorubicin—stomach cancer	4.14e-05	0.000121	CcSEcCtD
Ropinirole—Dizziness—Epirubicin—stomach cancer	4.12e-05	0.000121	CcSEcCtD
Ropinirole—Pruritus—Doxorubicin—stomach cancer	4.08e-05	0.000119	CcSEcCtD
Ropinirole—Vomiting—Epirubicin—stomach cancer	3.96e-05	0.000116	CcSEcCtD
Ropinirole—Nausea—Methotrexate—stomach cancer	3.96e-05	0.000116	CcSEcCtD
Ropinirole—Diarrhoea—Doxorubicin—stomach cancer	3.95e-05	0.000116	CcSEcCtD
Ropinirole—Rash—Epirubicin—stomach cancer	3.93e-05	0.000115	CcSEcCtD
Ropinirole—Dermatitis—Epirubicin—stomach cancer	3.93e-05	0.000115	CcSEcCtD
Ropinirole—Headache—Epirubicin—stomach cancer	3.91e-05	0.000114	CcSEcCtD
Ropinirole—Dizziness—Doxorubicin—stomach cancer	3.82e-05	0.000112	CcSEcCtD
Ropinirole—Nausea—Epirubicin—stomach cancer	3.7e-05	0.000108	CcSEcCtD
Ropinirole—Vomiting—Doxorubicin—stomach cancer	3.67e-05	0.000107	CcSEcCtD
Ropinirole—Rash—Doxorubicin—stomach cancer	3.64e-05	0.000106	CcSEcCtD
Ropinirole—Dermatitis—Doxorubicin—stomach cancer	3.63e-05	0.000106	CcSEcCtD
Ropinirole—Headache—Doxorubicin—stomach cancer	3.61e-05	0.000106	CcSEcCtD
Ropinirole—Nausea—Doxorubicin—stomach cancer	3.43e-05	0.0001	CcSEcCtD
Ropinirole—DRD2—Signaling Pathways—RHOA—stomach cancer	5.68e-06	3.7e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CXCL8—stomach cancer	5.67e-06	3.69e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CXCL8—stomach cancer	5.65e-06	3.68e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—HRAS—stomach cancer	5.64e-06	3.67e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MAPK3—stomach cancer	5.63e-06	3.67e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—STAT3—stomach cancer	5.63e-06	3.66e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL6R—stomach cancer	5.62e-06	3.66e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—MTHFR—stomach cancer	5.62e-06	3.66e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—NOS3—stomach cancer	5.62e-06	3.66e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—HRAS—stomach cancer	5.61e-06	3.65e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—IL6—stomach cancer	5.59e-06	3.64e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—RHOA—stomach cancer	5.58e-06	3.64e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—IL6—stomach cancer	5.58e-06	3.63e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—MYC—stomach cancer	5.57e-06	3.62e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—MAPK1—stomach cancer	5.56e-06	3.62e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—EGFR—stomach cancer	5.56e-06	3.62e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CDKN1B—stomach cancer	5.54e-06	3.61e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—NOS3—stomach cancer	5.53e-06	3.6e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—MAPK1—stomach cancer	5.52e-06	3.59e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—EGFR—stomach cancer	5.52e-06	3.59e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CDKN1B—stomach cancer	5.51e-06	3.59e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PTGS2—stomach cancer	5.5e-06	3.58e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CXCL8—stomach cancer	5.49e-06	3.58e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MYC—stomach cancer	5.48e-06	3.57e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CCND1—stomach cancer	5.48e-06	3.57e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—JUN—stomach cancer	5.46e-06	3.56e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—HRAS—stomach cancer	5.46e-06	3.55e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—TYMS—stomach cancer	5.45e-06	3.55e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—MAPK1—stomach cancer	5.45e-06	3.55e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—EGFR—stomach cancer	5.44e-06	3.55e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CD44—stomach cancer	5.42e-06	3.53e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—IL6—stomach cancer	5.4e-06	3.51e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GSTM1—stomach cancer	5.39e-06	3.51e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MAPK3—stomach cancer	5.38e-06	3.5e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—IL6—stomach cancer	5.37e-06	3.5e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CDKN1B—stomach cancer	5.36e-06	3.49e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—VEGFA—stomach cancer	5.36e-06	3.49e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MAPK1—stomach cancer	5.36e-06	3.49e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—EGFR—stomach cancer	5.36e-06	3.49e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—PIK3CA—stomach cancer	5.35e-06	3.48e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MMP9—stomach cancer	5.32e-06	3.46e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—STAT3—stomach cancer	5.31e-06	3.46e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CDKN1A—stomach cancer	5.3e-06	3.45e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—VEGFA—stomach cancer	5.29e-06	3.44e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CCND1—stomach cancer	5.29e-06	3.44e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—JUN—stomach cancer	5.28e-06	3.44e-05	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	5.27e-06	3.43e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	5.27e-06	3.43e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—PIK3CA—stomach cancer	5.26e-06	3.43e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CCND1—stomach cancer	5.26e-06	3.42e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—ERBB2—stomach cancer	5.25e-06	3.42e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—KRAS—stomach cancer	5.25e-06	3.42e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—JUN—stomach cancer	5.25e-06	3.42e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—STAT3—stomach cancer	5.24e-06	3.41e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MYC—stomach cancer	5.23e-06	3.4e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—IL6—stomach cancer	5.22e-06	3.4e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	5.21e-06	3.39e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CAV1—stomach cancer	5.18e-06	3.37e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MAPK8—stomach cancer	5.17e-06	3.37e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—APOA1—stomach cancer	5.17e-06	3.37e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—ERBB2—stomach cancer	5.17e-06	3.37e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—KRAS—stomach cancer	5.14e-06	3.35e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MMP9—stomach cancer	5.13e-06	3.34e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CCND1—stomach cancer	5.12e-06	3.33e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MAPK1—stomach cancer	5.12e-06	3.33e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—EGFR—stomach cancer	5.11e-06	3.33e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CDKN1A—stomach cancer	5.11e-06	3.33e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MMP9—stomach cancer	5.11e-06	3.32e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—JUN—stomach cancer	5.1e-06	3.32e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CDKN1A—stomach cancer	5.09e-06	3.31e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—RHOA—stomach cancer	5.08e-06	3.31e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MAPK3—stomach cancer	5.07e-06	3.3e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ERCC2—stomach cancer	5.06e-06	3.3e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—KRAS—stomach cancer	5.06e-06	3.3e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—NOS3—stomach cancer	5.03e-06	3.27e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MAPK3—stomach cancer	5e-06	3.26e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MAPK8—stomach cancer	4.99e-06	3.25e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CXCL8—stomach cancer	4.98e-06	3.24e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MMP9—stomach cancer	4.97e-06	3.23e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MAPK8—stomach cancer	4.97e-06	3.23e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—HRAS—stomach cancer	4.95e-06	3.22e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CDKN1A—stomach cancer	4.95e-06	3.22e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MYC—stomach cancer	4.93e-06	3.21e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CXCL8—stomach cancer	4.9e-06	3.19e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—HRAS—stomach cancer	4.87e-06	3.17e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CDKN1B—stomach cancer	4.87e-06	3.17e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MYC—stomach cancer	4.87e-06	3.17e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—KRAS—stomach cancer	4.83e-06	3.15e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MAPK8—stomach cancer	4.83e-06	3.15e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—PIK3CA—stomach cancer	4.83e-06	3.14e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MAPK1—stomach cancer	4.82e-06	3.14e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—EGFR—stomach cancer	4.82e-06	3.14e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	4.79e-06	3.12e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CDKN1B—stomach cancer	4.79e-06	3.12e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—VEGFA—stomach cancer	4.77e-06	3.11e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MAPK1—stomach cancer	4.76e-06	3.1e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—MTHFR—stomach cancer	4.76e-06	3.1e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—EGFR—stomach cancer	4.76e-06	3.1e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—IL6—stomach cancer	4.74e-06	3.08e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—STAT3—stomach cancer	4.73e-06	3.08e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—PIK3CA—stomach cancer	4.73e-06	3.08e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	4.7e-06	3.06e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TP53—stomach cancer	4.67e-06	3.04e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—IL6—stomach cancer	4.66e-06	3.04e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—PIK3CA—stomach cancer	4.65e-06	3.03e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CCND1—stomach cancer	4.64e-06	3.02e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—JUN—stomach cancer	4.63e-06	3.02e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PPP2R1A—stomach cancer	4.61e-06	3e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—VEGFA—stomach cancer	4.61e-06	3e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—VEGFA—stomach cancer	4.59e-06	2.99e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TP53—stomach cancer	4.57e-06	2.98e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CCND1—stomach cancer	4.57e-06	2.97e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—STAT3—stomach cancer	4.56e-06	2.97e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—JUN—stomach cancer	4.56e-06	2.97e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—KRAS—stomach cancer	4.56e-06	2.97e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PPARG—stomach cancer	4.56e-06	2.97e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—STAT3—stomach cancer	4.54e-06	2.96e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTP1—stomach cancer	4.52e-06	2.94e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MAPK3—stomach cancer	4.52e-06	2.94e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MMP9—stomach cancer	4.51e-06	2.93e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TP53—stomach cancer	4.5e-06	2.93e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—KRAS—stomach cancer	4.5e-06	2.93e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CDKN1A—stomach cancer	4.49e-06	2.92e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—HRAS—stomach cancer	4.47e-06	2.91e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—HMOX1—stomach cancer	4.46e-06	2.9e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	4.46e-06	2.9e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—VEGFA—stomach cancer	4.46e-06	2.9e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—PIK3CA—stomach cancer	4.44e-06	2.89e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MMP9—stomach cancer	4.43e-06	2.89e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	4.43e-06	2.89e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CDKN1A—stomach cancer	4.42e-06	2.88e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—STAT3—stomach cancer	4.42e-06	2.88e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MYC—stomach cancer	4.39e-06	2.86e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CAV1—stomach cancer	4.39e-06	2.86e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MAPK8—stomach cancer	4.38e-06	2.85e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—APOA1—stomach cancer	4.38e-06	2.85e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—HRAS—stomach cancer	4.37e-06	2.85e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MAPK3—stomach cancer	4.36e-06	2.84e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	4.36e-06	2.84e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MAPK3—stomach cancer	4.34e-06	2.82e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MAPK8—stomach cancer	4.31e-06	2.81e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—HRAS—stomach cancer	4.3e-06	2.8e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MAPK1—stomach cancer	4.3e-06	2.8e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—EGFR—stomach cancer	4.3e-06	2.8e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TP53—stomach cancer	4.29e-06	2.8e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—IL6—stomach cancer	4.27e-06	2.78e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—IL6—stomach cancer	4.24e-06	2.76e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MYC—stomach cancer	4.24e-06	2.76e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MAPK3—stomach cancer	4.22e-06	2.75e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MYC—stomach cancer	4.22e-06	2.75e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—TYMS—stomach cancer	4.2e-06	2.74e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.19e-06	2.73e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—PIK3CA—stomach cancer	4.19e-06	2.73e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—IL6—stomach cancer	4.18e-06	2.72e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—PIK3CA—stomach cancer	4.17e-06	2.71e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTM1—stomach cancer	4.16e-06	2.71e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCND1—stomach cancer	4.16e-06	2.71e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MAPK1—stomach cancer	4.15e-06	2.7e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—EGFR—stomach cancer	4.15e-06	2.7e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—JUN—stomach cancer	4.15e-06	2.7e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—PIK3CA—stomach cancer	4.13e-06	2.69e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MAPK1—stomach cancer	4.13e-06	2.69e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—EGFR—stomach cancer	4.13e-06	2.69e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—IL6—stomach cancer	4.12e-06	2.68e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—HRAS—stomach cancer	4.11e-06	2.67e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MYC—stomach cancer	4.1e-06	2.67e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—ALB—stomach cancer	4.1e-06	2.67e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—KRAS—stomach cancer	4.06e-06	2.64e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TP53—stomach cancer	4.05e-06	2.64e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—VEGFA—stomach cancer	4.05e-06	2.63e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MMP9—stomach cancer	4.03e-06	2.63e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	4.02e-06	2.62e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MAPK1—stomach cancer	4.01e-06	2.61e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—EGFR—stomach cancer	4.01e-06	2.61e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—STAT3—stomach cancer	4.01e-06	2.61e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TP53—stomach cancer	4e-06	2.6e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—VEGFA—stomach cancer	3.98e-06	2.59e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—STAT3—stomach cancer	3.94e-06	2.57e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—IL6—stomach cancer	3.93e-06	2.56e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	3.92e-06	2.55e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—NOS3—stomach cancer	3.92e-06	2.55e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—KRAS—stomach cancer	3.92e-06	2.55e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ERCC2—stomach cancer	3.91e-06	2.54e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—KRAS—stomach cancer	3.9e-06	2.54e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—HRAS—stomach cancer	3.87e-06	2.52e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PPARG—stomach cancer	3.86e-06	2.51e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MAPK3—stomach cancer	3.83e-06	2.49e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—HRAS—stomach cancer	3.82e-06	2.49e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—KRAS—stomach cancer	3.79e-06	2.47e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MAPK3—stomach cancer	3.77e-06	2.45e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—PIK3CA—stomach cancer	3.73e-06	2.43e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MYC—stomach cancer	3.72e-06	2.42e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—IL6—stomach cancer	3.71e-06	2.41e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—MTHFR—stomach cancer	3.67e-06	2.39e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MYC—stomach cancer	3.66e-06	2.39e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—IL6—stomach cancer	3.66e-06	2.38e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MAPK1—stomach cancer	3.64e-06	2.37e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—EGFR—stomach cancer	3.64e-06	2.37e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	3.62e-06	2.36e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TP53—stomach cancer	3.61e-06	2.35e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	3.6e-06	2.34e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—STAT3—stomach cancer	3.59e-06	2.34e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MAPK1—stomach cancer	3.58e-06	2.33e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PTGS2—stomach cancer	3.58e-06	2.33e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—EGFR—stomach cancer	3.58e-06	2.33e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PIK3CA—stomach cancer	3.58e-06	2.33e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PIK3CA—stomach cancer	3.48e-06	2.27e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TP53—stomach cancer	3.48e-06	2.27e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ALB—stomach cancer	3.47e-06	2.26e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TP53—stomach cancer	3.46e-06	2.26e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—HRAS—stomach cancer	3.45e-06	2.25e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—KRAS—stomach cancer	3.44e-06	2.24e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	3.43e-06	2.23e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CAV1—stomach cancer	3.39e-06	2.21e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—KRAS—stomach cancer	3.38e-06	2.2e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PIK3CA—stomach cancer	3.38e-06	2.2e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—APOA1—stomach cancer	3.38e-06	2.2e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TP53—stomach cancer	3.37e-06	2.19e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MYC—stomach cancer	3.33e-06	2.17e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—HRAS—stomach cancer	3.33e-06	2.17e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—NOS3—stomach cancer	3.32e-06	2.16e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—HRAS—stomach cancer	3.31e-06	2.16e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—IL6—stomach cancer	3.3e-06	2.15e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	3.26e-06	2.12e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—EGFR—stomach cancer	3.26e-06	2.12e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—HRAS—stomach cancer	3.22e-06	2.1e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—IL6—stomach cancer	3.19e-06	2.08e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—IL6—stomach cancer	3.17e-06	2.06e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PIK3CA—stomach cancer	3.16e-06	2.06e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PIK3CA—stomach cancer	3.11e-06	2.02e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IL6—stomach cancer	3.08e-06	2.01e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—KRAS—stomach cancer	3.08e-06	2.01e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TP53—stomach cancer	3.06e-06	1.99e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PTGS2—stomach cancer	3.04e-06	1.98e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TP53—stomach cancer	3.01e-06	1.96e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PPARG—stomach cancer	2.98e-06	1.94e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—HRAS—stomach cancer	2.92e-06	1.9e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—HRAS—stomach cancer	2.88e-06	1.87e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	2.83e-06	1.84e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL6—stomach cancer	2.8e-06	1.82e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL6—stomach cancer	2.75e-06	1.79e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TP53—stomach cancer	2.74e-06	1.78e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ALB—stomach cancer	2.68e-06	1.74e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—HRAS—stomach cancer	2.62e-06	1.7e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—NOS3—stomach cancer	2.56e-06	1.67e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL6—stomach cancer	2.51e-06	1.63e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTGS2—stomach cancer	2.34e-06	1.53e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CA—stomach cancer	2.2e-06	1.44e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.87e-06	1.22e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.44e-06	9.39e-06	CbGpPWpGaD
